Discovery of E3 Ligase Ligands for Target Protein Degradation
Target protein degradation has emerged as a promising strategy for the discovery of novel therapeutics during the last decade. Proteolysis-targeting chimera (PROTAC) harnesses a cellular ubiquitin-dependent proteolysis system for the efficient degradation of a protein of interest. PROTAC consists of...
Main Authors: | Jaeseok Lee, Youngjun Lee, Young Mee Jung, Ju Hyun Park, Hyuk Sang Yoo, Jongmin Park |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/19/6515 |
Similar Items
-
PROTACs: A novel strategy for cancer drug discovery and development
by: Xin Han, et al.
Published: (2023-06-01) -
PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective
by: Xin Han, et al.
Published: (2022-05-01) -
E3 ligase ligand optimization of Clinical PROTACs
by: Hanrui Jiang, et al.
Published: (2023-01-01) -
Proteasomal Degradation of Zn-Dependent Hdacs: The E3-Ligases Implicated and the Designed Protacs That Enable Degradation
by: Laura Márquez-Cantudo, et al.
Published: (2021-09-01) -
Pharmacophore-based ML model to filter candidate E3 ligands and predict E3 Ligase binding probabilities
by: Reagon Karki, et al.
Published: (2024-01-01)